Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD300 molecule like family member D (CD300LD) is a member of the CD300 family of immunoglobulin superfamily receptors, typically classified as a type I transmembrane protein found on immune cells[6][1][5]. It is predicted to function as both an activating and inhibitory receptor, participating in the modulation of immune responses and inflammatory signaling[3][5]. In mice, it has been identified as a functional virus receptor for murine norovirus, dictating species tropism[7]. CD300LD is involved in regulation of cytokine production, including interleukin-6 and tumor necrosis factor, and is implicated in a variety of immune system pathways, such as innate immunity and antigen processing[5][6]. Like other CD300 family members, its ability to bind exposed lipids on cell surfaces links it to the recognition of dead or activated immune cells, suggesting a potential role in infection, inflammation, and immune homeostasis[3][5][6]. No approved therapeutic drugs, validated clinical biomarkers, or specific safety concerns for this target in humans have been reported in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD300 molecule like family member D (CD300LD).